All News #Library
Biotech
AmMax Bio Announces First Patients Dosed in Phase 2b Study of AMB-05X for TGCT
30 Jan 2023 //
GLOBENEWSWIRE
AmMax Bio`s AMB-05X Receives EMA PRIME Designation for the Treatment of TGCT
19 Jan 2023 //
GLOBENEWSWIRE
AmMax Enters into an Agreement with Evopoint to License ADC
09 Jan 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support